This inventor holds 1 USPTO granted patent. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Yoshiaki Hamamoto: Innovator in HIV Research
Introduction
Yoshiaki Hamamoto is a notable inventor based in Ube, Japan. He has made significant contributions to the field of medical research, particularly in the area of HIV. His innovative work has led to the development of a unique patent that addresses critical challenges in HIV research.
Latest Patents
Yoshiaki Hamamoto holds a patent for an "Antigenic noninfectious HIV-producing cloned T cell." This invention involves a cloned T cell prepared by infecting a human T cell, H9, with HTLV-III B. The cloned human T cell is antigenic for HTLV-III B, does not have syncytium-forming activity, and does not produce infectious HTLV-III B virions. This patent represents a significant advancement in the understanding and treatment of HIV.
Career Highlights
Hamamoto is associated with Banyu Pharmaceutical Co. Ltd., where he has been able to apply his research and innovations in a practical setting. His work has contributed to the development of therapeutic strategies aimed at combating HIV.
Collaborations
Yoshiaki Hamamoto has collaborated with notable colleagues, including Nobuyuki Kobayashi and Naoki Yamamoto. These collaborations have further enhanced the impact of his research in the scientific community.
Conclusion
Yoshiaki Hamamoto's contributions to HIV research through his innovative patent and collaborations highlight his role as a key figure in the field. His work continues to inspire advancements in medical science and offers hope for improved treatments for HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile